Skip to main content


The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss the use of continuous glucose monitors in clinical trials. The lively discussion is expected to have a great impact on propelling the use of Time in Range globally. Continue Reading »

Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss these results and more at the ATTD 2022 conference in Barcelona, Spain. Continue Reading »

​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications. Continue Reading »

Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies. Continue Reading »

At ATTD 2022, several researchers presented on projects aimed at understanding and addressing the impact of hypoglycemia. While diabetes technology is helpful and effective, it can only go so far. Read about other approaches in minimizing the harm that hypoglycemia can cause. Continue Reading »

The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top highlights. Continue Reading »

once weekly insulin with semaglutide GLP-1 clinical trial

Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide, can help people with type 2 diabetes better manage their glucose levels and lose weight.  Continue Reading »

The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years! Find out what sessions and presenters we are most excited to see. Continue Reading »